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Introduction
Alveolar bone loss is a major concern, especially after tooth 
extraction. To overcome the alveolar bone loss and to increase 
support (in order to place dental implants, for example), many bone 
regenerative substitutes are available, such as: allografts, autografts, 
xenografts, synthetic biomaterials and osteoactive agents [1].
Calcium phosphate ceramics are one of the most used groups of 
synthetic bone substitutes [2], because of its similarity to the mineral 
phase of natural bone, absence of immunogenic reactions, excellent 
biocompatibility and osteoconductive potential [3].
Although calcium phosphate ceramics contribute to bone healing 
through osteoconduction, they generally lack osteoinductivity. 
Due to these limitations, surgeons and researchers have focused 
on developing alternative therapies, particularly studying the 
combination of osteoprogenitor cells, like mesenchymal stem cells 
(MSCs), with bone substitutes to improve their osteogenic properties 
[4].
Some studies indicate that increasing the number of grafted 
MSCs, associated with calcium phosphate ceramics biomaterials, 
result in better bone formation. This might be related to the crucial 
role of MSCs in osteoinduction [5].
There are many MSCs, such as: bone marrow-derived 
mesenchymal stem cells, umbilical cord blood-derived mesenchymal 
stem cells, adipose tissue-derived stem cells, muscle-derived 
stem cells and dental pulp stem cells [6]. Bone marrow was the 
most used source of MSCs. However, in recent years, dental stem 
cells have received extensive attention in the field of bone tissue 
engineering due to their easy access for dentists and oral surgeons, 
immunosuppressive properties, high proliferation, and the capacity 
to differentiate into odontoblasts, cementoblasts, osteoblasts, and 
other cells to be found in dental tissues [7,8].
The aim of the present review is to analyse the current state of the 
art about dental stem cells and their potential in oral medicine bone 
regeneration.
Material and Methods
A systematic search was made in the PubMed database.
The following combination of keywords was used: dental stem 
cells, osteoinduction, gene induction, osteointegration, stem cells 
isolation, mesenchymal stem cells, bone regeneration, scaffolds, and 
regulation factors.
Mainly review articles, clinical trials and case-reports were 
selected. Time frame of publication date was set from 2010 until 
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Abreviations 
MSC: Mesenchymal Stem Cells, DSC: Dental Stem Cells, DPSCs 
- Dental Pulp Stem Cells, SHEDs: Stem Cells from Exfoliated 
Deciduous Teeth, SCAPs: Stem Cells from Apical Papilla, DLSCs: 
Periodontal Ligament Stem Cells, DFPCs: Dental Follicle Precursor 
Cells, BMMSCs: Bone Marrow Mesenchymal Stem Cells, BMP: 
Bone Morphogenic Protein, PLLA: Poly L-lactic Acid, ALP: 
Alkaline Phosphatase, BSP: Bone Sialoprotein, OSX: Ostenix, 
OPN: Osteopontin, PDGF: Plaquelet Derived Growth Factor, OC: 
Osteocalcin, Coll-1: Collagen Type I, CP23: Cementum Protein 
23, FGF2: Fibroblastic Growth Factor 2, TNFα: Tumoral Necrosis 
Factor α, VEGF: Vascular Endothelial Growth Factor, NF-κB: 
Necrosis Factor κB, CEMP1: Cementum Protein 1, HIF1: Hypoxia 
Induction Factor 1, FGF9: Fibroblastic Growth Factor 9, HA/TCP– 
Hidroxiapatite + Tri-calcium phosphate
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2015, and only papers available in English were included. The papers 
selection was performed by considering the presence of keywords 
in the title and abstract, and their relevancy to the research that has 
been made. Then, each paper was selected individually according to 
its content.
Results and Discussion
Types of dental stem cells
Dental tissues have been considered a potential source of MSC-
like populations [9].
With the exception of enamel, which lacks ameloblasts or other 
cellular elements following tooth development, the periodontium and 
dentine continue to retain some regenerative or reparative capacities 
[10].
Dental MSCs are indicated for the regeneration of the dentin–
pulp complex, bone, cartilage and neuronal tissues, among others 
[10,11]. Until recently, five different populations have been isolated 
and characterized in postnatal dental tissues and classified according 
to the tissue of origin: dental pulp stem cells (DPSCs), stem cells from 
exfoliated deciduous teeth (SHEDs), stem cells from apical papilla 
(SCAPs), periodontal ligament stem cells (PDLSCs) and dental 
follicle precursor cells (DFPCs) [9,12] (Table 1).
Dental pulp stem cells (DPSCs): DPSCs are multipotent stem 
cells, with ectomesenchymal origin, which have advantages for 
clinical applications when compared to other mesenchymal stem 
cells derived from bone marrow, adipose tissue, peripheral blood, 
and umbilical cord blood. They are easily available from discarded 
teeth after extraction and they can be cryopreserved, retaining their 
multipotent differentiation ability [9,13].
The differentiation potential of DPSCs from natal teeth to 
adipogenic, osteogenic, chondrogenic, myogenic and neural-glial 
cells lines was also shown, and an intrinsic tendency of these cells to 
differentiate towards osteoblasts has been demonstrated [13].
Sometimes DPSCs are referred to as odontoblastoid cells, 
because they appear to synthesize and secrete dentin matrix like the 
odontoblast that they replace [14]. When transplanted in vivo (using 
immunocompromised mice as hosts), the cells derived from dental 
pulp generated functional dental tissue in the form of complexes like 
dentine/pulp. This might be due to the origin of their development as 
neural crest derived cells [12]. When cultured in ceramic substrates, 
such as hydroxyapatite or tricalcium phosphate, the cells are able to 
form bone, dentin and cementum-like tissues [9].
Stem cells from exfoliated deciduous teeth (SHEDs): SHED is 
a heterogeneous multicellular population of stem cells [15] identified 
as highly proliferative clonogenic cells capable of differentiating 
into a variety of cell types including neural cells, adipocytes and 
odontoblasts [12]. SHED cells represent a population of multipotent 
stem cells that are more immature than the DPSCs and, in vivo, they 
seem to be able to induce bone or dentin formation [13,14].
Also, SHED cells exhibit higher proliferation rates, increased 
population doublings, osteoinductive capacity and ability to form 
sphere-like clusters when compared to DPSCs [12].
Stem cells from apical papilla (SCAPs): The cells located in 
the apical papilla (root foramen area) represent another unique 
population of dental stem cells [12].  As long as the root develops, the 
dental papilla’s location moves in an apical direction [13]. These cells 
show ability to differentiate into cells of the osteogenic, odontogenic, 
adipogenic, and neurogenic lineages [9]. It is thought that SCAPs 
may be responsible for the formation of primary odontoblasts that 
account for the formation of root dentin, whereas DPSCs seem to 
be the source of replacement odontoblasts that produce reparative 
dentine [9,12,13]. To conclude, SCAPs are derived from a developing 
tissue that may represent a population of early stem/progenitor 
cells, which may be a superior cell source for tissue regeneration 
[13], since they also showed other favourable characteristics, such as 
higher proliferative rate, telomerase activity and improved migration 
capacity [14-16].
Periodontal ligament stem cells (PDLSCs): The periodontal 
ligament provides nourishment to the teeth, regulates periodontal 
homeostasis and contains a population of progenitor cells – 
periodontal ligament stem cells [12]. PDLSCs are capable of 
differentiating into cells resembling cementoblasts, osteoblasts, 
adipocytes, chondrocytes, and fibroblasts [9]. This population seems 
to be more proliferative, have a faster cell growth rate and higher 
clonogenic capability than bone marrow mesenchymal stem cells 
(BMMSCs) [9,16]. These cells maintain their tissue regenerative 
potential even after recovery from frozen human tissue, which 
suggests the possibility of cryopreserved PDLSCs from extracted 
teeth being used for future therapeutic purposes [12].
Dental follicle precursor cells (DFPCs): Dental follicle stem cells 
exist in the dental follicle (loose connective tissue sac surrounding 
the enamel organ and the dental papilla of the developing tooth germ 
before eruption) [9,12].  These cells were first isolated from the follicle 
of human impacted third molars [14]. In vitro, following adequate 
induction, DFPCs have been demonstrating osteogenic, odontogenic 
and cementogenic differentiation capacity [9].
Gingiva as a source of stem cell: Progenitor cells and multipotent 
MSC subpopulation of cells have been isolated and characterised 
from gingival fibroblasts. These fibroblasts are easily accessible and 
have recently been used to derive induced pluripotent stem cell lines 
[12].
Collection, isolation and preservation of dental stem cells
Collection: The main source of dental stem cells is extracted 
teeth. A freshly extracted tooth is transferred into a vial containing 
transport solution and generally hypotonic phosphate buffered saline 
solution. The vial is carefully sealed and placed into a thermette and 
Table 1: Therapeutic application of oral MSCs
DPSCs
These cells seem to be of great importance concerning periodontal regeneration as well as bone and dentin regeneration. However, 
further work on the subject needs to be developed [23,52,53] 
On the other hand, they have been able to generate a dentin pulp-like complex [11,16,53].
PDLSCs
These stem cells seem to be capable of generating bone, cementum, periodontal ligament-like structures and to increase 
periodontal regeneration [16,52]. When compared to other mesenchymal stem cells they appear to be more indicated when 
periodontal regeneration is intended [11,52].
SHEDs
This group of stem cells are believed to be a valuable alternative when periodontal regeneration is intended and also demonstrate 
the ability to reconstitute a dentin pulp-like complex [11,16,52,53].
Moreover, SHED have shown bone regenerative capacity [16,23,53].
SCAPs
These stem cells demonstrated positive results in what concerns the formation of dentin pulp-like complex [11,16,23,54].
Associated with PDLSCs, SCAPs were able to form a root-like structure when seeded onto hydroxyapatite-based scaffolds and 
implanted in pig jaws [52,54].
DFPCs
The micro-environments where this stem cells are implanted have great importance to determine which tissues they are capable of 
forming (e.g. DFPCs implanted in the non-mineralized omental pocket contributed to dentin regeneration; DFPCs implanted in the 
highly mineralized skull contributed to matrix formation; DFPCs implanted in the alveolar fossa contributed to the formation of root 
like tissues with a pulp-dentin complex and a periodontal ligament connecting a cementum-like layer to host alveolar bone). Another 
important information provided by these studies is that DFPCs demonstrated high potential towards tooth roots regeneration [52].
Moreover, this group of stem cells is also capable of generating a bone/cementum-like tissue [16].
Rodrigues et al. Int J Stem Cell Res Ther 2015, 2:1 • Page 3 of 5 •ISSN: 2469-570X
then the carrier is placed into an insulated metal transport vessel. The 
thermette, along with the insulated transport vessel, maintains the 
sample in a hypothermic state during transportation. This procedure 
is described as sustentation. The time from harvesting to arrival at the 
processing storage facility should not exceed 40 hours [17].
DPSCs samples are obtained from dental pulp tissue from 
extracted third molars, exfoliating/extracted deciduous teeth and 
teeth extracted for orthodontic treatment, trauma or periodontal 
disease [18,19], while PDLSCs are obtained via scraping the mid 
third of the root in extracted teeth. SCAPs are isolated from the apical 
papilla tissue and can easily be removed from an extracted tooth with 
developing roots (very common in third molar extractions) [19-23].
Isolation: Almost every author uses a method of their own, 
which makes a detailed analysis of all experimental works impossible. 
Consequently, several studies need to be done in order to systematize 
laboratorial procedures [23].
The two methods most frequently used for DPSCs isolation 
are Enzyme-digestion and Explant outgrowth. Other methods like 
Magnetic activated cell sorting (MACS) and Fluorescence activated 
cell sorting (FACS) are also available [17,24-27].
Regardless of the chosen isolation method, common procedure 
dictates that the tooth surface is cleaned by washing it three times 
with phosphate buffered saline (PBSA) without Ca2+ and Mg2+. The 
next step is disinfection followed by another washing with PBSA. Pulp 
tissue is isolated from the pulp chamber and placed into a sterile petri 
dish, washed at least three times with PBSA [17,25,26].
Enzyme-digestion method: Small pieces of pulp tissues are 
transferred into an enzyme solution, often collagenase/dispase, for 
30-60min at 37°C. Afterwards, large cell aggregates are removed 
and single-cell suspensions are obtained by passing cells through a 
cell strainer. Single-cell suspensions are centrifuged for 5 min at 
room temperature.  Suspensions are then seeded in culture dishes 
containing proliferation medium and incubated at 37°C in 5% 
CO2. Culture medium can be substituted every three days until cell 
confluence is achieved [17,24-27].
Explant outgrowth method: Pulp tissue is placed in culture flasks 
with proliferation medium and then incubated at 37°C in 5% CO2. 
Medium must be changed after outgrowth is observed [17,24-27].
A modified efficient method for dental pulp stem cell isolation: 
Recently, an additional method has been proposed. The main 
difference relies on the digestion of pulp tissues and fixing them under 
a cover slip in the medium. This new method provided a greater in 
vitro expansion compared to the two methods mentioned above. 
Moreover, the cells were less damaged and were, therefore, healthy 
enough to propagate longer in vitro than with other methods [24,26].
Preservation: Once the tissue samples are obtained, they are 
transferred under proper conditions to a tooth bank where they are 
stored. The approaches used for stem cell storage are cryopreservation 
and magnetic freezing [17].
Cryopreservation: Cryopreservation is the process of preserving 
cells or whole tissues by cooling them at sub-zero temperatures. 
Liquid nitrogen vapour is used to preserve cells at a temperature 
below -150°C. Cryopreservation of stem cells maintains the viability 
of these cells indefinitely [17].
Magnetic freezing: This technology is referred to as cells alive 
system (CAS), which works on the principle of applying a weak 
magnetic field to water or cell tissue, which will lower the freezing 
point of that body by up to 6–7°C. Using CAS, Hiroshima University 
(first proposed this technology) claims it can increase cell’s survival 
rate in teeth up to 83%. CAS system is a lot less expensive and more 
reliable than cryogenics [17].
Comparison of human mesenchymal stem cells derived 
from dental pulp and bone marrow
BMMSCs are a population of multipotent, non-hematopoietic 
marrow-derived cells that are easily expanded in culture and 
differentiated into cells with an osteogenic phenotype [19].
Bone marrow was the first identified source of a cell referred as a 
MSC. These cells were the earliest discovered and well-known stem 
cell population used in bone tissue engineering [28].
Although they are widely studied and have presented favourable 
results, there was a need to search other alternative cell sources to 
overcome the disadvantages that these cells present, specially the 
morbidity associated to their collection.  The main disadvantages of 
BMMSCs are the low stem cell yield from aspirated bone marrow, 
painful and highly invasive procedure of collection, as well as the 
decline, over time, of the number, proliferative capacity and maximal 
lifespan of MSCs derived from bone marrow [29].
Dental stem cells have emerged in the recent past as an alternative 
source to MSCs. They are considered multipotent cells with a high 
proliferation rate, opportunity to be safely cryopreserved, possessing 
immunosuppressive properties and expressing mesenchymal markers. 
They also have multi-differentiation ability, easy accessibility, high 
viability and ready ability to be induced into multiple cell lineages, 
such as: odontoblasts, adipocytes, neuronal-like cells, glial cells, 
osteoblasts, chondrocytes, melanocytes, myotubes, and endothelial 
cells [8,30,31].
PSCs share similar characteristics with BMMSCs. However, it 
is notable that DPSCs are superior to BMMSCs in certain aspects 
[32]. These cells have differences in expression of pluripotent stem 
cell genotype when compared to other types of MSCs. This might 
reflect their embryonic stem cell origin. Dental pulp is made of 
ectomesenchymal elements, containing neural crest-derived cells, 
which display plasticity and multipotential capabilities [5].
Ponnaiyan D et al. concluded that MSCs derived from dental 
pulp proliferate much faster than MSCs from bone marrow [7]. 
The authors demonstrated that DPSCs exhibit a significantly higher 
proliferation rate than BMMSCs and are, therefore, more appropriate 
for cell-based therapy in clinical application. This result may be due 
to the age related state of respective tissues, since DPSCs were isolated 
from third molars (the last permanent teeth to evolve and erupt at 
an earlier stage of development). In contrast to BMMSCs, DPSCs 
were more restricted in their adipocyte differentiation capacity, while 
exhibiting a stronger ability for osteoblast differentiation [30].
Many studies confirm the ability of DPMSCs to undergo 
osteogenic differentiation and their capacity of forming vascularized 
adult bone. Integration between the graft and the surrounding host 
blood supply was achieved [5,21,32,33]. Mori et al. also successfully 
induced DPSCs into osteoblasts [34].
Although the majority of studies support the advantages of DPSCs 
over other types of stem cells, there are some which claim opposite 
conclusions. Asatrian G et al. advocate that while dental pulp might 
pose as an alternative site for MSCs isolation, the use of DMSCs is 
limited by the small quantity of pulp in a tooth, by the proportionally 
smaller DMSC yield required for their expansion by long-term 
culture and the corresponding costs and risks that are incurred. Thus, 
according to this study, DPMSCs do not supplant therapies enlisting 
BMMSCs [35].
Bone tissue regeneration using DSCs - recent advances
In recent years, bone tissue regeneration has proven to be 
achievable using MSCs from the oral cavity. This is presented as an 
evolutionary step from common practiced clinical techniques such as 
the use of rich plasma alone or scaffolds carrying BMPs. Furthermore, 
bone regeneration is achieved in more significant capacity using stem 
cells than with previous methods [36]. Therefore, it is important to 
review the latest developments in the research of factors which may 
affect stem cells’ potential as a biomaterial.
Scaffold architecture and composition
Scaffolds simulate an extracellular matrix in a three dimensional 
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model, as a carrier of signalling molecules aiming towards stimulation, 
differentiation and migration of cells, ultimately with the purpose of 
tissue regeneration [16].
Nanofibrous PLLA scaffolds are preferable to Solid Wall 
ones, as they exhibit higher adherence, proliferation and cellular 
differentiation values. Also, greater mineral deposition has been 
achieved in the matrix in vitro. Higher ALP activity, development of 
dense tissue (detected via sialoprotein concentration) and collagen 
levels have also been reported in vivo [37].
In recent times, Biocoral Scaffolds comprising DPSCs revealed 
elevated genomic expression of osteoblastic lines, along with high 
local values of BSP and osteocalcin. It was possible to observe DPSCs 
migration towards the inside of Biocoral pores, where the secretion 
of extracellular matrix and osteoblastic differentiation occurred [38].
Scaffolds HA/TCP carrying PDLSCs corrected furcation defects 
(Class II and III) combined with cementum and periodontal 
regeneration, after 12 weeks, in animal models. In vitro studies also 
verified positive results regarding osteogenesis and in vivo studies 
equally established favourable clinical and radiographic results. 
PDLSCs revealed the potential for the development of lamina-dura 
around titanium implants in vivo [16]. MSC Spheroids, in conjunction 
with osteoblastic induction agents, over the course of 7 days, have 
shown accelerated osteogenic properties, higher calcic deposition 
and bone regeneration in vivo, with significant increase in osteogenic 
markers concentration (OSX - 8.27x, RUNX2 - 1.57x, OPN – 1.94x, 
BSP – 1.33x) [39].
Genetic and nutritive regulation
Bone morphogenic proteins have long been utilized in scaffolds 
as stimulants for a hastened growth of bone matrix and cartilage [40]. 
Presently, the transfection of genetic factors to cellular populations 
in scaffolds, namely PDLSCs, resulted in an escalation of PDGF, with 
greater cementoblastic activity than reported in recombinant PDGF 
delivery [41].
A mutant variety of RUNX2 (a major transcription factor for 
bone development and osteologic differentiation) in which the 
C-terminal 5 amino-acid chain is missing, conveyed higher OC, OP, 
Coll-1 and CP23 concentrations in scaffolds prepared in vitro. Similar 
results have been achieved when the cells were stimulated with FGF2. 
Genetic regulation of cells was obtained through gene introduction 
via viral vectors and by incorporating the cell medium with genes 
in the form of recombinant proteins [42]. Bobby Sox has also been 
studied as a regulator of osteoblastic gene expression in DPSCs, with 
stem cell proliferation increasing 6.5 times over a period of 7 days 
when present. BBX variant 1 and 2 cDNA were previously cloned and, 
afterwards, overexpressed when electroporated in progenitor cells 
using a microporator. The knockdown of BBX using shRNA did not 
affect mineralization but a decrease in osteoblastic gene expression 
was observed. Neither procedure modulated cell proliferation [43].
A shift in miRNA expression in DSC populations undergoing 
osteoblastic differentiation has been detected with miRNA-218 being 
associated with mineralized tissue formation and downregulation 
of RUNX2. MiRNA-218 quantity analysis was conducted using a 
nanodrop spectrophotometer at baseline (day 0) when the peak 
expression of RUNX2 was detected [44].
Implant site determinants
Angiogenic and pro-inflammatory responses have been studied as 
means to regulate DPSCs’ proliferation. Short-term exposure to TNFα 
induces cellular death through an increase in angiogenic signalling 
(VEGF) and NF-κB, which, once prematurely inhibited, promote 
mineralization. Long-term exposure prompts cellular proliferation 
through an increase in anti-apoptotic genes (BCL2) and Survivin [45].
Dexamethasone has been described as having an osteogenic 
impulse on PDLSC in vitro, vindicated by an upturn in intracellular 
calcium, ALP and mineralization. Two times more frequently calcified 
nodules were noted between days 21 and 28 of the experiment 
conducted, therefore leading to the question of a possible genetic 
induction being carried out by Dexamethasone [46].
Human serum has been studied as an option to substitute 
bovine serum as a support for osteomorphic inducting markers for 
DPSCs, solving possible disease transmission issues and xenogenic 
immune response, which both may occur when bovine serum is used. 
Human serum displayed higher cellular proliferation (13% more 
at each cellular cycle), greater surface expression of typical DPSC 
antigens, more significant mineral deposition, more ALP activity, 
and moreover, an increase in surrounding ossification in bone graft 
implanted in vivo [47].
CEMP1 has been reported as an inducer of cementoblastic 
phenotypes in PDLSCs. In relative hypoxic states, while the local 
oxygen tension is reduced, CEMP1 expression rises, leading to further 
mineral deposition. This mechanism may be regulated by means of 
HIF1 [48].
DFSCs showed maximum proliferation rates at heat-stress 
temperatures in the 39°C to 40°C interval, concomitant with 
higher expression of osteogenic markers, when compared to 37°C 
physiological temperature [49].
Other studies conducted
Led Nitrate (Pb2+) posed a threat to adhesion of DPSCs and 
PDLSCs in scaffold matrixes, with changes to cell morphology, higher 
osteogenic deregulation and cells expressing local markers associated 
to stem lineages (Oct4, Rex1). Lower proliferation and mineralization 
rates were also observed [50].
FGF9 induces phosphorylation of ERK1/2, therefore it inhibits 
osteogenic induction of DPSCs. BMP in scaffold matrix may be able 
to compensate for this effect, especially since FGF9 also upregulates 
angiogenesis (VEGF) leading to an ostegenic effect [51].
Conclusion
MSCs are available for extraction from the oral cavity without 
performing invasive techniques. Various cell populations express 
stem cell markers, diverse differentiation and clinical application 
potentials, such as regenerative endodontics and periodontal 
regeneration among others.
The most deeply studied group of cells with maxilo-facial bone 
regeneration capacity are DPSCs, SHEDs and PDLSCs. All of these 
displayed promising both in in-vitro and in-vivo results, especially 
when compared to other widely utilized stem cell groups such as 
BMMSC. However, comparisons are still controversial among the 
scientific community. Other oral MSCs still lack extensive research 
and so far have not demonstrated much bone regeneration potential. 
Furthermore, many factors implied in scaffold architecture and 
composition, gene induction, cell nutrition and general medium 
exposures regulate cell proliferation, mineralized matrix deposition 
and osteogenic markers’ expression on cellular surface.
Oral stem cell research exhibits a large potential for development, 
with a broad spectrum of clinical applications to be considered in the 
coming years.
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